From: News coverage of drug development: implications for the conveyance of health information
Information source | Number of reports | Percentage |
---|---|---|
Human source | ||
Pharmaceutical company member | 47 | 36.7% |
Researcher | 40 | 31.3% |
Physician | 11 | 8.6% |
Governmental official | 10 | 7.8% |
Non-human source | ||
Pharmaceutical company | 28 | 21.9% |
Journal article | 18 | 14.1% |
Regulatory body | 16 | 12.5% |
Press conference | 11 | 8.6% |
Academic conference | 10 | 7.8% |